Table 4.
Differences in expected screening rates in November 2020 vs. November 2019 by race.
| Cancer | Race | Nov 2019 rate | Nov 2020 rate | IRR | p-value |
|---|---|---|---|---|---|
| Breast | Latinx | 0.041 | 0.026 | 0.621 | 0.024 |
| Breast | Asian | 0.037 | 0.026 | 0.694 | 0.094 |
| Breast | Black | 0.039 | 0.035 | 0.908 | 0.633 |
| Breast | White | 0.046 | 0.047 | 1.027 | 0.856 |
| Breast | Overall | – | – | – | 0.192 |
| Cervical | Latinx | 0.036 | 0.043 | 1.190 | 0.402 |
| Cervical | Asian | 0.034 | 0.036 | 1.034 | 0.897 |
| Cervical | Black | 0.034 | 0.041 | 1.213 | 0.285 |
| Cervical | White | 0.037 | 0.043 | 1.163 | 0.393 |
| Cervical | Overall | – | – | – | 0.398 |
| Colorectal | Latinx | 0.020 | 0.017 | 0.865 | 0.668 |
| Colorectal | Asian | 0.020 | 0.015 | 0.756 | 0.244 |
| Colorectal | Black | 0.020 | 0.018 | 0.882 | 0.492 |
| Colorectal | White | 0.021 | 0.017 | 0.833 | 0.361 |
| Colorectal | Overall | – | – | – | 0.666 |
| Lung | Latinx | 0.012 | 0.017 | 1.386 | 0.054 |
| Lung | Asian | 0.016 | 0.020 | 1.224 | 0.645 |
| Lung | Black | 0.018 | 0.028 | 1.562 | 0.006 |
| Lung | White | 0.021 | 0.028 | 1.348 | 0.054 |
| Lung | Overall | – | – | – | 0.014 |
[1] Wald p-value based on testing for null hypothesis that expected rates in November 2020 differs from those in November 2019 (for each race and overall).
[2] Nov 2019 and Nov 2020 rates refer to expected incidence rates of screening based on the model.
[3] Ratio refers to IRR for Nov 2020 rate by the Nov 2019 rate.